Michael Labarre News Today

Halozyme Therapeutics Inc (NASDAQ:HALO), a biopharmaceutical company known for its novel enzyme technology that targets the extracellular matrix, has recently witnessed a significant insider sell transaction.

On October 17, 2023, Michael Labarre, the Senior Vice President and Chief Technical Officer of Halozyme Therapeutics Inc (NASDAQ:HALO), sold 10,000 shares of the company.

Sixth graders from the Scotts Ridge Middle School chorus led by Michael LaBarre, delighted @Ridgefieldps BOE meeting. Watch it here =>